EAM
GMAB icon

Eagle Asset Management’s Genmab GMAB Stock Holding History

Eagle Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$285K Buy
12,356
+1,121
+10% +$30K ﹤0.01% 522
2024
Q2 		$279K Sell
11,235
-154
-1% -$4.37K ﹤0.01% 554
2024
Q1 		$345K Sell
11,389
-73
-0.6% -$2.14K ﹤0.01% 552
2023
Q4 		$365K Sell
11,462
-497
-4% -$15.6K ﹤0.01% 526
2023
Q3 		$422K Sell
11,959
-333
-3% -$12.7K ﹤0.01% 504
2023
Q2 		$467K Sell
12,292
-471
-4% -$18.8K ﹤0.01% 494
2023
Q1 		$481K Buy
12,763
+51
+0.4% +$1.96K ﹤0.01% 502
2022
Q4 		$546K Sell
12,712
-183
-1% -$7.54K ﹤0.01% 497
2022
Q3 		$414K Sell
12,895
-365
-3% -$12.8K ﹤0.01% 511
2022
Q2 		$430K Buy
+13,260
New +$430K ﹤0.01% 524

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Eagle Asset Management's GMAB Position: Q3 2024 in Review

Eagle Asset Management increased its Genmab (GMAB) stake by 10% in Q3 2024, buying an estimated $30K and bringing the position to 12,356 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Eagle Asset Management first reported a position in GMAB in Q2 2022 and has held it in 10 quarters since. The position peaked at $546K in Q4 2022. 223 funds tracked by Wall St. Rank hold GMAB as of Q3 2024.

  • Eagle Asset Management held 12,356 shares of Genmab worth $285K as of Q3 2024.
  • Eagle Asset Management bought 1,121 Genmab shares in Q3 2024, an estimated $30K.
  • Genmab made up ﹤0.01% of Eagle Asset Management's portfolio in Q3 2024, its #522 holding.
  • Eagle Asset Management first reported a position in Genmab in Q2 2022 and has held it in 10 quarters since.
  • Eagle Asset Management's Genmab position peaked at $546K in Q4 2022.
  • 223 funds tracked by Wall St. Rank held Genmab as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.